#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunodeficiency common variable Dilated cardiomyopathy Prodromal Alzheimer's disease Uveitis Cerebral arteriovenous malformation haemorrhagic Cholangiosarcoma Kidney transplant rejection Optic glioma Scedosporium infection Epileptic encephalopathy Cytomegalovirus infection Rheumatoid arthritis Metastatic malignant melanoma Angiosarcoma non-metastatic Encephalitis autoimmune More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma – Diagnostics Carcinoid syndrome – Diagnostics Undifferentiated sarcoma – Trials in Disease Synovial sarcoma Angiosarcoma non-metastatic – Trials in Disease Hepatic angiosarcoma – Trials in Disease Lymphatic malformation – Diagnostics Vascular malformation SAPHO syndrome – Diagnostics Gaucher’s disease type III More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-Histidine Urapidil Ttx-030 D-Camphor Munc-T3 Fludrocortisone Giroctocogene Fitelparvovec Prednisolone Corylus Avellana L. Enomimeran Dirocaftor Threonine L-Threonine Phenazone Estradiol Valerate Jk08 Furosemide Ph. Eur. GRAPHITE Apadamtase Alfa Vemircopan More therapies…

    Learn about Your Condition

    Fallopian tube cancer Intestinal obstruction Lymphocyte adoptive therapy Postoperative wound infection Angiosarcoma recurrent Malignant melanoma Enteritis Osteoporosis postmenopausal Cervix carcinoma recurrent Cluster headache Cystic fibrosis Brain injury Vascular graft thrombosis Weaning failure Pneumonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety and Effects of Iptacopan in Children with Paroxysmal Nocturnal Hemoglobinuria (PNH) Aged 2 to 17 Years

    Recruiting

    3 1 1
    Investigated Drugs:
    • Iptacopan Hydrochloride
    France Germany Italy The Netherlands Spain

  • Study on Oxytocin’s Effects on Trust and Learning in Healthy Children Using Nasal Spray

    Recruiting

    1 1 1
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Study on Dopaminergic Pathway Disruption in Comatose Patients with Traumatic Brain Injury Using [18F]LBT-999

    Recruiting

    4 1 1
    Investigated Diseases:
    • Craniocerebral injury
    France

  • Study on the Effectiveness of Atovaquone and Proguanil for Malaria Prevention in Healthy Volunteers

    Recruiting

    2 1 1
    Investigated Drugs:
    • ATOVAQUONE
    • Proguanil Hydrochloride
    Germany

  • Study Comparing Ifinatamab Deruxtecan and Docetaxel for Patients with Advanced Prostate Cancer Resistant to Hormone Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    • Betamethasone Sodium Phosphate
    • Buclizine Hydrochloride
    Austria Czechia Denmark France Germany Greece +7

  • Study on Safe Skin Test Concentrations for Biotherapy Allergies in Patients with Cancer Using Atezolizumab, Daratumumab, and Nivolumab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma
    • Primary amyloidosis
    • Malignant melanoma
    Investigated Drugs:
    • Cemiplimab
    • Atezolizumab
    • Daratumumab
    France
Previous Page
1 … 199 200 201 202 203 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!